Litcius/Paper detail

Folic acid-doxorubicin polymeric nanocapsules: A promising formulation for the treatment of triple-negative breast cancer

Rodrigo Cé, Gabriela Klein Couto, Barbara Zoche Pacheco, Danieli Rosane Dallemole, Júlia Damé Fonseca Paschoal, Bruna Silveira Pacheco, Sı́lvia Stanisçuaski Guterres, Fabiana K. Seixas, Tiago Collares, Adriana Raffin Pohlmann

2021European Journal of Pharmaceutical Sciences26 citationsDOI

Topics & Concepts

DoxorubicinClonogenic assayTriple-negative breast cancerPharmacologyCancer researchApoptosisBreast cancerChemistryViability assayPopulationFlow cytometryIn vivoNanocapsulesPaclitaxelCancer cellChemotherapyCancerMedicineImmunologyBiologyBiochemistryInternal medicineMaterials scienceNanoparticleEnvironmental healthBiotechnologyNanotechnologyNanoparticle-Based Drug DeliveryCancer, Lipids, and MetabolismAdvanced biosensing and bioanalysis techniques
Folic acid-doxorubicin polymeric nanocapsules: A promising formulation for the treatment of triple-negative breast cancer | Litcius